Skip to Content


Active Substance: depreotide trifluoroacetate
Common Name: depreotide
ATC Code: V09IA05
Marketing Authorisation Holder: CIS bio international
Active Substance: depreotide trifluoroacetate
Status: Withdrawn
Authorisation Date: 2000-11-29
Therapeutic Area: Radionuclide Imaging
Pharmacotherapeutic Group: Diagnostic radiopharmaceuticals

Therapeutic Indication

This medicinal product is for diagnostic use only.
For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, in
combination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.

The marketing authorisation for NeoSpect has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.